Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (IMPT Study)

Clinical trial NCT05504135 · COMPLETED

Trial details

NCT number: NCT05504135
Sponsor: Nalagenetics Pte Ltd
Status: COMPLETED
Study type: OBSERVATIONAL

Pre-emptive Pharmacogenomics

Start date: 2022-10-03
Primary completion: 2023-08-31
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.